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ABSTRACT Phospholamban is an integral membrane protein that regulates the contractility of cardiac muscle by maintaining
cardiomyocyte calcium homeostasis. Abnormalities in association of protein kinase A with PLB have recently been linked to
human heart failure, where a single mutation is responsible for dilated cardiomyopathy. To date, a high-resolution structure of
phospholamban in a lipid environment has been elusive. Here, we describe the ﬁrst structure of recombinant, monomeric,
biologically active phospholamban in lipid-mimicking dodecylphosphocholine micelles as determined by multidimensional NMR
experiments. The overall structure of phospholamban is ‘‘L-shaped’’ with the hydrophobic domain approximately perpendicular
to the cytoplasmic portion. This is in agreement with our previously published solid-state NMR data. In addition, there are two
striking discrepancies between our structure and those reported previously for synthetic phospholamban in organic solvents: a),
in our structure, the orientation of the cytoplasmic helix is consistent with the amphipathic nature of these residues; and b),
within the hydrophobic helix, residues are positioned on two discrete faces of the helix as consistent with their functional roles
ascribed by mutagenesis. This topology renders the two phosphorylation sites, Ser-16 and Thr-17, more accessible to kinases.
INTRODUCTION
Phospholamban, a 52-residue membrane protein, regulates
myocardial contractility by direct physical interaction with
Ca-ATPase, a 110-kDa enzyme that maintains calcium
homeostasis in the sarcoplasmic reticulum. Since its discov-
ery in the early 1970s as a regulator of cardiac contractility, the
structure of PLB has been the subject of intense research and
debate (MacLennan et al., 2002; Simmerman and Jones,
1998). To date, a high-resolution structure of full-length PLB
(52 amino acids) has been elusive due to the hydrophobic
nature of this protein and its propensity to aggregate.
Structural insights have been gained from various mutagen-
esis, cross-linking, circular dichroism, Fourier transform
infrared spectroscopy, electron paramagnetic resonance, and
light-scattering studies (Thomas et al., 1998). The self-
association of PLB is characterized by a dynamic monomer-
pentamer equilibrium regulated by the phosphorylation of
residues Ser-16 and Thr-17 (Thomas et al., 1998). It is the
monomer that preferentially binds and inhibits the sarcoplas-
mic reticulum Ca-ATPase (Reddy et al., 1999). However, the
mechanistic details of this protein-protein interaction remain
obscure. In the widely accepted enzymatic mechanism, the
Ca-ATPase undergoes a substantial transition from a high
Ca21 afﬁnity (E1) to a low Ca21 afﬁnity (E2) conformation,
with both phosphorylation and magnesium ATP complex
binding to Ca-ATPase powering the calcium translocation
process (Stokes and Wagenknecht, 2000). Based on gel
electrophoresis in detergent solution (Arkin et al., 1997;
Kimura et al., 1997) and on ﬂuorescence resonance energy
transfer experiments in membranes (Reddy et al., 1999), PLB
is thought to assemble into a pentamer and to depolymerize
into monomers before interacting with Ca-ATPase. Sub-
sequently, the monomeric form of PLB inhibits calcium ﬂux
upon binding to the E2 form of the enzyme at submicromolar
Ca21. This inhibitory interaction is reversed by phosphory-
lation at Ser-16 and Thr-17 upon adrenergic stimulation of the
cardiac myocyte (Tada and Kadoma, 1989).
Mutagenesis studies and coimmunoprecipitation assays
suggest that the interaction between PLB and Ca-ATPase
involves all three structural domains of PLB: domain IA, an
amphipathic helix; domain IB, a short hinge; and domain II,
a highly hydrophobic helix. In particular, these studies point
out that PLB’s inhibitory activity occurs via intramembra-
nous interactions between a functionally discrete helical face
of domain II and TM domains 4 and 6 of Ca-ATPase, with
both domains IA and IB ‘‘ﬁne-tuning’’ the inhibition by
interacting with the stalk and the cytoplasmic domains of
the enzyme (MacLennan et al., 1998; MacLennan and
Toyofuku, 1986). The other face of the domain II helix is
involved in the formation of PLB TM leucine zipper that
stabilizes PLB pentamers (Karim et al., 1998; Simmerman
et al., 1996).
Therefore, the regulation of the Ca-ATPase enzymatic
cycle by PLB may involve both protein-protein and protein-
lipid interactions. It is likely that PLB depolymerization
occurs ﬁrst, as PLB-PLB interactions in the pentamer are
replaced by PLB-lipid interactions with a substantial change
in PLB’s conformation. Subsequently, PLB-lipid interac-
tions are replaced by PLB-Ca-ATPase interactions, with
PLB undergoing a further conformational change. A better
understanding of all the possible stages of this complex
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mechanism requires the elucidation of both protein-protein
and protein-lipid interactions at the atomic level.
The high-resolution x-ray crystal structures of the
SERCA1a isoform of Ca-ATPase in its E1 and E2 forms,
obtained by Toyoshima and co-workers, have revealed many
interesting features of this complex enzyme, opening up
the possibility of understanding the atomic details of its
regulatory process (Toyoshima et al., 2000; Toyoshima and
Nomura, 2002). In addition, electron microscopy of Ca-AT-
Pase/PLB cocrystals has helped formulate several different
mechanistic hypotheses that remain to be tested (Toyoshima
et al., 1993). Although detailed information on the structure
of Ca-ATPase has been obtained, a complete study of the
interaction of PLB and lipids has not yet been published.
In our recent article, we have determined the topology of
monomeric PLB in mechanically oriented lipid bilayers by
solid-state NMR spectroscopy (Mascioni et al., 2002b). Our
ﬁndings a), rule out the possibility of a continuous a-helical
structure for unbound monomeric PLB; b), demonstrate that
domain II is oriented approximately perpendicularly to the
plane of the bilayers; and c), show that the cytosolic, amp-
hipathic helix interacts with the lipid bilayer surface. The
intent of the present article is to build on these results by
elucidating the high-resolution solution structure of PLB and
its interaction with a lipid environment. As with our previous
studies, we have focused our investigation on a fully func-
tional, monomeric PLB mutant in which the three TM
cysteines have been replaced by A36, F41, and A46,
respectively (AFA-PLB). These mutations destabilize the
pentamer formation presumably by interfering with the
packing interaction between the individual helices (Fujii
et al., 1989; Simmerman et al., 1996; Karim et al., 1998,
2000). Our high-resolution structure of PLB in detergent
micelles will be a natural complement to the results obtained
by solid-state NMR spectroscopy and will help lay the
groundwork for future studies of PLB/Ca-ATPase interac-
tions.
METHODS
Expression and puriﬁcation
A detailed protocol for recombinant production of phospholamban has been
submitted elsewhere (Buck et al., 2003). In brief, Escherichia coli
BL21(DE3) cells (Novagen, Darmstadt, Germany) were transformed using
a modiﬁed MBP/AFA-PLB fusion construct (Invitrogen, Carlsbad, CA).
The culture was grown by shaking overnight to OD600 of ;1.0 at 250 rpm
and 258C. Cells were transferred (1:50) into standard M9 minimal media
supplemented with vitamins and minerals (mineral mixture: 6 mg/L, CaCl2;
6 mg/L, FeSO4; 1 mg/L, MnCl2; 0.8 mg/L CoCl2; 0.7 mg/L, ZnSO4; 0.3
mg/L, CuCl2; 0.02 mg/L, H3BO3; 0.25 mg/L, (NH4)6MO7O24; 5 mg/L
EDTA; vitamin mixture: 1 mg/L, calcium pentothenate; 1 mg/L, biotin;
1 mg/L, folic acid; 1 mg/L, niacinamide; 1 mg/L, pyridoxal phosphate) until
an OD600;1.0. Cells were induced with 1 mM IPTG and harvested after 6 h
at 378C. AFA-PLB pellets were resuspended on ice in 200-mL lysis buffer
(20 mM PBS, pH 8.0, 120 mM NaCl, 1 mM EDTA, 0.1 mM DTT, 0.5%
glycerol, 2 ug/mL pepstatin A, 2 mg/mL leupeptin, 2.5 mM lysozyme, 0.5
mM PMSF, 8 mM Triton X100). The suspension was then homogenized
with a cell grinder and sonicated using a Branson Soniﬁer 450 (Branson
Ultrasonic, Danbury, CT). Cells were pelleted by centrifugation at 18,000
rpm for 20 min at 48C, and the supernatant was collected for further
puriﬁcation. AFA-PLB was puriﬁed to homogeneity with afﬁnity chroma-
tography using amylose resin (New England Biolabs, Beverly, MA), after
cleavage with TEV protease and size exclusion chromatography with
Sephacryl S-100 matrix (Pharmacia, Piscataway, NJ).
NMR spectroscopy
All NMR spectra were recorded using a Varian INOVA spectrometer
(Varian, Palo Alto, CA) operating at 800 MHz at 508C, with the exception of
the exchange and topology data, which were acquired at 600 MHz. An
inverse detection triple-resonance and triple-axis gradient probe was used.
All the pulse sequences used were equipped with pulse ﬁeld gradients for
both coherence selection and sensitivity enhancement schemes. Quadrature
detection was obtained using States-TPPI schemes. NMR samples were
prepared by dissolving ;2 mg (0.8 mM) of lyophilized PLB-AFA into 400
mL of 20 mM aqueous sodium phosphate buffer (pH 4.2) and 600 mM
dodecylphosphocholine (Anatrace, Maumee, OH). 1H chemical shifts were
referenced directly to 3-(trimethylsilyl)-1-propane-sulfonic acid sodium salt
(Aldrich, Milwaukee, WI) at 0 ppm, whereas 15N and 13C were indirectly
referenced (Wishart et al., 1995). Complete backbone assignment was
determined using triple resonance experiments HNCA, HN(CO)CA,
HNCACB, HN(CO)CACB, and HNCO. Side-chain chemical shifts were
derived from 15N total correlation spectroscopy-HSQC with a mixing time
of 70 ms and NOEs were obtained from 15N edited NOESY-HSQC
experiments with a mixing time of 150 ms. NMR spectra were processed
using NMRPipe (Delaglio et al., 1995) and analyzed using NMRView
software (Merck, Whitehouse Station, NJ).
Hydrogen/deuterium exchange factors
15N uniformly labeled PLB-AFA samples were lyophilized and resuspended
in solutions containing 10%, 30%, 50%, and 70% D2O, respectively, and the
HSQC spectra were obtained after a ﬁxed 30-min incubation period at room
temperature. The intensities of the amide resonances in the HSQC spectra
were measured using the NMRView software. The values were normalized
to those found in the sample with 10% D2O. The peak intensities were
plotted as a function of the mole fraction of H2O in the solution, and the
exchange factors, x, were determined using Eq. 1,
ðyCÞ1 ¼ xð1 XÞ=X1 1; ð1Þ
where y is the peak volume, C is a normalization factor, and X the mole
fraction of H2O in the solution. The experiments were performed at 508C and
378C (Veglia et al., 2002).
PLB localization in DPC micelles
The localization of PLB relative to the micelle surface was established using
paramagnetic relaxation agents, Mn21, 5-, and 16-doxylstearic acid. By
observing the line broadening of the amide resonances in the HSQC spectra
and quantifying the percentage of signal retention due to the paramagnetic
effect, it is possible to position the PLB relative to the micelle surface
(Damberg et al., 2001). Upon addition to the DPC micellar solution, the
Mn21 causes a line broadening of the solvent-exposed residues. In the case
of 5-doxylstearic acid, the aliphatic chains are buried in the micelle
hydrocarbon region, whereas the radical group is placed closer to the
micelle/water interface. For 16-doxylstearic acid, only the intensities of
resonances buried in the micellar core are quenched. Incremental
concentrations of Mn21, 5-, and 16-doxylstearic acid in the range of 0.2–
6.4 mM were used with a protein sample at 0.8 mM. For the ﬁnal analysis,
we chose concentrations of paramagnetic agents sufﬁcient to observe a signal
reduction of ;50% for the most exposed residues.
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Structure calculations
Structure calculations were performed using Xplor-NIH software (Brunger
et al., 1998). We started our calculations from PLB in an extended structure
(Nilges et al., 1988). Using the hybrid molecular dynamics SA protocol at
a temperature of 4000 K (Stein et al., 1997), we generated 100 structures.
Subsequently, these structures were reﬁned using a further SA step and
energy minimization. The ﬁnal reﬁnement was carried out using the
‘‘reﬁne_gentle.inp’’ protocol, which gradually introduces the van der Waals
radii. A total of 392 NOEs were classiﬁed in ‘‘strong’’ (1.8–2.8 A˚),
‘‘medium’’ (1.8–3.5 A˚), and ‘‘weak’’ (1.8 5.0 A˚) NOEs and used in the
structure calculations, of which 150 were intraresidue and 242 interresidue
NOEs. A total of 29 hydrogen bond constraints were incorporated at the end
of our preliminary calculations. Torsion angle restraints were obtained from
TALOS (http://spin.niddk.nih.gov/bax/software/TALOS) using the chem-
ical shift values of Ca, Cb, C9, N, and Ha as inputs (Cornilescu et al., 1999).
The few ambiguous angles found in the loop region were assigned an
additional 608 of conformational freedom compared to their predicted
values. Of the 100 structures generated, the 20 lowest energy structures were
selected for further analysis. Those structures selected had no violations of
a), NOE constraints higher than 0.5 A˚; b), bond angles higher than 58; and c),
bond lengths higher than 0.05 A˚. The covalent geometry of the conformers
generated was determined using PROCHECK_NMR (Laskowski et al.,
1998).
RESULTS
Assignments and constraints
As with all membrane-bound peptides and proteins, sample
preparation is a key step in obtaining the high-resolution
spectra of PLB. In our analysis of different experimental
conditions, we found that PLB behaves well in both DPC and
sodium dodecyl sulfate micelles, giving rise to very well-
resolved and unique resonances for each of the amide sites.
Since our optimized PLB sample in sodium dodecyl sulfate
micelles gave 15N linewidths slightly larger than the sample
in DPC micelles, we chose the latter for our structure
determination. In an effort to optimize spectral resolution
and sensitivity, severalHSQCspectrawere acquired in a range
of 37–608C. Only marginal chemical shift changes were
observed for both the N- and C- termini and the more solvent-
exposed residues (17–23), whereas the majority of the resi-
dues did not exhibit any chemical shift variation, demon-
strating that the structure is essentially the same at all the
temperatures analyzed. The best compromise for both reso-
lution and sensitivity was found to be at 508C, and we have
chosen these conditions to carry out our NMR experiments.
The 1H/15N HSQC spectrum of PLB in DPC micelles is
reported in Fig. 1. All the amide peaks were assigned using a
combination of HNCA, HN(CO)CA, HNCACB, and CBCA
(CO)NH experiments. Several strips from the 3D HNCACB
‘‘walk’’ are reported in Fig. 2. Due to the high quality of the
spectra, the resonance assignment was straightforward, with
the exception of residues R-14 and L-39, in which amide and
Ca resonances are overlapped. This spectral ambiguity was
resolved using the chemical shifts of the Cb. The distinct
secondary structural elements deﬁned by the chemical shift
indices of Ha, Ca, Cb, and CO are indicated in Fig. 3.
The backbone-to-side chain NOEs were assigned using
1H/15N total correlation spectroscopy and NOESY-HSQC
experiments. The crosspeak intensities resulting from the
1H/15N NOESY-HSQC experiments were then classiﬁed as
‘‘strong,’’ ‘‘medium’’, or ‘‘weak’’ using the routine built in
the NMRView software package (Johnson and Blevins,
1994). A summary of the NOE crosspeak pattern is given in
Fig. 4. From the density daN(i, i 1 1), dNN(i, i 1 1), and
FIGURE 1 Fully assigned 1H/15N HSQC spectrum of AFA-PLB in
600 mM DPC micelles. The spectrum was recorded at 600 MHz at 508C.
FIGURE 2 Two-dimensional strips from three-dimensional 1H/15N/13C
HNCACB spectrum of AFA-PLB in DPC micelles. The data were recorded
at 800 MHz at 508C. Residue numbers denote the sequential connectivities.
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dbN(i, i1 1) NOE correlations, it is possible to identify three
distinct regions: an N-terminal helix, encompassing residue
2–16; a short connecting loop from residues 17 through 21;
and a third well-deﬁned helical region from residues 22
through 50. The two regions encompassing residues 2–16
and 22–50 show a remarkable number of dab(i, i 1 3), daN
(i, i 1 3), and daN(i, i 1 4) typical of regular a-helices. A
plot of the total number of NOEs per residue, including
both backbone and side chains, is shown in Fig. 5.
Structure calculations
All the measured distances and predicted dihedral angles
were subsequently modeled using SA calculations with the
Xplor-NIH program. Of the 100 conformers generated from
the simulated annealing calculations, the 20 lowest energy
structures were selected for further reﬁnement and analysis.
None of the 20 structures analyzed showed NOE violations
[0.5 A˚ or dihedral angle violations[58. The Ramachandran
plots generated using PROCHECK_NMR show that ;86%
of the residues fall into the most favored region, ;12% into
additional allowed regions, and \2% into generously
allowed regions. No residues are in the disallowed regions
(Table 1).
From the Ramachandran plots of each single amino acid, it
is possible to deﬁne the secondary structure segments. The
FIGURE 3 Chemical shift index histograms of AFA-PLB obtained from
triple resonance experiments (see Methods section).
FIGURE 4 Summary of the backbone NOEs obtained from 1H/15N
NOESY-HSQC experiments (top). Deuterium/proton exchange factors ob-
tained for AFA-PLB in DPCmicelles at 378C and 508C, respectively (bottom).
FIGURE 5 Histogram illustrating the number of intra- and interresidue
NOEs as a function of the residue. The asterisk denotes the presence of
ambiguous NOEs that were not included in the structural calculations.
However, their assignments were veriﬁed a posteriori.
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cytoplasmic a-helical region (or domain IA) spans from Glu-
2 to Ser-16. The short hinge (or domain IB) encompasses
residues Thr-17 through Pro-21. Although located in regions
typical of mobile loops, the f and c angles of these residues
do not fall into a typical b-turn conformation (type IV turn,
see Fig. 7, bottom). The hydrophobic helix (or domain II)
starts at residue Gln-22 and extends up to residue Met-50.
The juxtaposition of the backbones of the 20 lowest
energy three-dimensional structures generated using simu-
lated annealing calculations is reported in Fig. 6 A. By
ﬁtting the backbone Ca atoms of the overall structures with
the exception of the termini (residues 2–50), the RMSD is
3.4 A˚ for the backbone atoms and 4.5 A˚ for the side
chains. This relatively high RMSD is due to the ﬂexible
hinge connecting the two helical domains. For the Ca
atoms of domain IA (residues 2–16), the calculated
RMSDs are 0.36 and 1.71 A˚ for the backbone and side
chains, respectively. Superimposing domain II (residues
22–50), RMSDs of 0.48 and 1.48 A˚ are obtained for the
backbone and side chains, respectively. Fig. 6 shows the
superposition of the lowest energy conformers for the
overall structures (Fig. 6 A) and for the individual domains
(Fig. 6, B–D). The loop (Thr-17–Pro-21) determines the
‘‘L-shape’’ form of phospholamban. The network of NOEs
found in the loop region is depicted in Fig. 7. Several
NOEs found in this region, particularly those involving
Met-20 and Pro-21, were classiﬁed as ambiguous and were
not included in the ﬁnal calculations. However, their
assignments were veriﬁed a posteriori and found consistent
with the conformers generated.
Exchange factors
The hydrogen/deuterium (H/D) exchange factor method was
used to analyze the hydrogen bonds (Veglia et al., 2002).
Exchange factors reveal in more detail the nature and strength
of hydrogen bonds than do the classical H/D kinetic methods,
distinguishing both TM and in-plane helical domains of
membrane proteins solubilized in lipid micelles. Our results
for PLB in DPC micelles are reported in Fig. 4, where the
values of exchange factors versus residues are reported. The
bar histogram of exchange factors for PLB obtained at 378C
and 508C show that the resonances located between residues
33 and 52 have the lowest exchange factors, with an average
exchange factor (xav) of ;0.3, whereas the region between
residues 21 and 32 ismore solvent-exposedwith a value ofxav
; 1.0. The residues located in the cytoplasmic region of PLB
(4–18) have a value of xav ; 1.3, which is typical of helices
absorbed on the surface of micelles (Veglia et al., 2002), with
a gradual decrease in value going from residues 5 through 19.
The difference in x values throughout domain II of
phospholamban (residues 21–32 vs. 33–52 ) can be explained
by the partial embedding of this domain into the micelle. The
paramagnetic quenching data (see the following section)
TABLE 1 NMR-derived restraints and structural statistics for the 20 lowest energy conformers
NOE, hydrogen bonds, and dihedrals
Total NOE 392
Intraresidue 150
Interresidue 242
Hydrogen bonds 29
Dihedral angles (F/C) 42
Average energies (kcal mol1) Simulated annealing Reﬁnement
Etot 267.1 6 12.6 654.4 6 27.1
ENOE 79.9 6 3.9 81.5 6 6.7
Ebond 21.7 6 1.24 21.5 6 1.2
Eangle 113.8 6 8.1 115 6 6.9
Eimproper 21.9 6 2.4 23.4 6 2.6
EVDW 25.6 6 5.8 3.8 6 12.8
Restraint violations
[0.5 A˚ 0 0
RMSD (A˚)
Superposition Helix 1 Loop Helix 2
Residues 2–16 Residues 17–21 Residues 22–50
Backbone 0.36 6 0.13 0.43 6 0.19 0.48 6 0.20
Heavy atoms 1.71 6 0.28 1.31 6 0.34 1.48 6 0.19
Ramachandran analysis
Residues in most favored regions 86.2%
Residues in additional allowed regions 12.2%
Residues in generously allowed regions 1.6%
Residues in disallowed regions 0%
All the statistics were carried out using XPLOR software package (Brunger et al., 1998). Ramachandran analysis was carried out using PROCHECK_NMR.
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support this interpretation. In fact, residues 21–32 are less
hydrophobic and most likely positioned at the interface
between the detergent head groups and the bulk solvent. This
location renders these residues more susceptible to H/D
exchange than the hydrophobic residues 33–52.
Positioning in micelles
To probe the topological orientation of PLB in detergent
micelles, we used three different paramagnetic relaxation
agents: a), Mn21; b), 5-doxyl stearic acid; and c), 16-doxyl
stearic acid. Manganese ions were used to probe solvent-
FIGURE 6 Stereo view of the superposition of
the 20 lowest energy structures of AFA-PLB: (A)
Backbone representation of the 20 conformers
(superposition of residues 2–50). (B) Superposi-
tion of residues 2–16 of domain IA of AFA-PLB.
(C) Superposition of residues 17–21 of the
ﬂexible loop domain IB. (D) Superposition of
residues 22–50 of domain II of AFA-PLB.
FIGURE 7 Network of NOEs found in the loop region
imposing the ‘‘L-shape’’ topology on AFA-PLB in
micelles and the corresponding distribution of f and c
angles deﬁning the turn.
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exposed residues, whereas both 5-doxyl and 16-doxyl stearic
acids were used for membrane-embedded residues (Damberg
et al., 2001). Our results are summarized in Fig. 8. Mn21
ions cause a reduction in the resonance intensities of residues
located at both termini and in the ﬂexible hinge (Fig. 8 A).
The effect is more pronounced at Mn21/protein ratios[3:1,
where most of the solvent-exposed residues are totally
quenched (Fig. 8 B). Although Ser-16 and Thr-17 do not
completely disappear at Mn21/protein ratios \3:1, their
intensities are dramatically reduced. At Mn21/protein ratios
[3:1, both Ser-16 and Thr-17 resonances are completely
quenched, demonstrating that these phosphorylation sites are
solvent-exposed (Fig. 8 B).
On the other hand, 5-doxyl and 16-doxyl stearic acids
cause a reduction in the resonance intensities of amino acids
located in the proximity of the micellar core. Although this
effect is only marginal for 5-doxyl, the addition of 16-doxyl
stearic acid caused a dramatic change in the resonance
intensities of these residues. In particular, with a 16-doxyl
stearic acid/PLB ratio of 4:1, we measured a substantial
reduction in the intensities of domain II (Fig. 8 C).
Interestingly, the intensity of Leu-7, which is located in
domain IA, is also reduced by the addition of 16-doxyl
stearic acid. Taken with the low x value for Leu-7, this result
indicates that Leu-7 is most likely buried in the hydrocarbon
region of the micelles. These effects are even more apparent
with a 16-doxyl stearic acid/PLB ratio of 8:1. Under these
experimental conditions, all the resonances of the TM
domain disappear and some of the resonances of domain IA
are also considerably reduced (Fig. 8D). Other resonances of
the cytoplasmic domains such as Tyr-6, Thr-8, and Ala-11
and the ﬂexible loop are only slightly reduced by the
interaction with 16-doxyl stearic acid. The two phosphory-
lation sites (Ser-16 and Thr-17) are not inﬂuenced by
addition of either 5-doxyl or 16-doxyl stearic acid (Fig. 8 C),
providing further evidence that these residues are solvent-
exposed. Moreover, in the presence of 16-doxyl stearic acid,
there is a noticeable periodicity of the resonance intensities
for the cytoplasmic helix (Fig. 8 C). The most quenched
residues point toward the micellar core, whereas the less
quenched residues face the bulk solvent, demonstrating that
this domain is indeed absorbed on the surface of the micelle.
Fig. 8 E summarizes the paramagnetic quenching results
as a surface plot of AFA-PLB highlighting solvent-exposed
and buried residues. These data are consistent with the
electrostatic potential plot of this molecule illustrated in
Fig. 8 F.
In light of the H/D exchange factors and our topological
studies with paramagnetic agents, we have further analyzed
the lowest-energy structures generated from the simulated
annealing calculations. Among the 20 conformers, 14 show
the side chains of all the hydrophobic amino acids of domain
IA (Val-4, Leu-7, Ala-11, and Ala-15) oriented toward the
interior of the micelles (Fig. 9), whereas the remainder of the
structures exhibit a less-deﬁned orientation for those
residues. These 14 structures are in best agreement with
both our topological studies and the amphipathic character of
domain IA.
FIGURE 8 Paramagnetic quenching obtained for AFA-
PLB in DPC micelles using Mn21 and 16-doxyl stearic
acid. (A) Intensity retention plot for AFA-PLB in the
presence of 0.8 mM of MnCl2 (1:1 Mn
21/protein molar
ratio). (B) Intensity retention plot for AFA-PLB in the
presence of 2.4 mM of MnCl2 (3:1 Mn
21/protein molar
ratio). (C) Intensity retention plot for AFA-PLB in the
presence of 3.2 mM of 16-doxyl stearic acid (4:1 16-doxyl
stearic acid/protein molar ratio). (D) Intensity retention
plot for AFA-PLB in the presence of 6.4 mM of 16-doxyl
stearic acid (1:8 16-doxyl stearic acid/protein molar ratio).
(E) Surface plot of AFA-PLB illustrating solvent-exposed
(coral) and buried (green) residues for histograms in A and
C. (F) Electrostatic potential plot of AFA-PLB showing
the hydrophobic patch centered at Leu-7.
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DISCUSSION
Given its remarkable biological importance and its relatively
small size, PLB has been the benchmark used by many
theoretical and experimental studies of membrane protein
structure and assembly. Solution NMR studies in organic
mixtures have shown that PLB adopts an ‘‘L-shape’’
structure with the intervening domain IB in either a short
ﬂexible turn or a b-turn type III conformation (Lamberth
et al., 2000; Pollesello et al., 1999). In both reported
structures, the interhelical angle between domain II and
domain IB was found to be 68 6 238. Spectroscopic and
modeling studies have also produced two rather different
structural models of pentameric PLB. In the ﬁrst model, PLB
is composed of two a-helices connected by a small
intervening b-sheet, with domain IA tilted at 50–608 relative
to the bilayer surface (Tatulian et al., 1995). In the second
model, full-length PLB has a continuous a-helix of ;40
amino acids with a tilt of 28 6 68 with respect to the bilayer
(Arkin et al., 1995; Smith et al., 2001).
There are major differences between the structures of PLB
obtained previously in organic solvents versus the present
structure in DPC micelles. These structures differ in a), the
lengths of each individual domain; b), the orientation of the
cytoplasmic helix with respect to the lipid phase; and c),
conformation of the TM domain. In principle, these might be
considered only subtle structural discrepancies. However,
these topological differences have substantial implications
for the interpretation of biological data for this important
membrane protein. The helix of domain IA for the structure
of monomeric PLB in triﬂuoroethanol spans residues 3–18,
whereas in the chloroform/methanol mixture this helix spans
residues 4–16. Under our experimental conditions, we found
that domain IA spans residues 2–16 with Thr-17 at the
beginning of the structured loop. Domain IB plays an
important role in the association with Ca-ATPase. In our
structural model, domain IB forms a type-IV b-turn. Our
results are in agreement with the structure in triﬂuoroethanol
(residues 18–21) describing the loop as a ‘‘turn’’, whereas in
chloroform/methanol the loop comprises residues 17–20 and
forms a type-III b-turn. We also found that Pro-21 is
positioned in the ﬂexible hinge, breaking the helical
conformation, whereas in the chloroform/methanol structure,
Pro-21 is part of the TM domain. Both structural models
obtained in organic solvents show two phosphorylation sites
(Ser-16 and Thr-17) facing domain II that are postulated to
be directly in contact with the polar headgroups of the
membranes. On the contrary, in our model, both Ser-16 and
Thr-17 side chains are oriented away from the lipid water
interface and contact the bulk solvent where they are more
accessible to interaction with cAMP-dependent protein
kinases (PKA) and calmodulin-dependent kinase, respec-
tively. Similarly, the two arginine residues (Arg-9 and Arg-
13) face domain II in the structures obtained in organic
solvents, whereas they are oriented toward the bulk solvent
in our structure. Furthermore, in our model the orientation of
domain IA matches the amphipathic character of the helix,
placing the charged side chains toward the bulk solvent
and the hydrophobic residues toward the lipid phase (Fig.
9, A–D). Finally, in the chloroform/methanol structure the
TM domain presents a notable kink that disrupts the dis-
crete helical faces deﬁned by the mutagenesis studies
(Kimura et al., 1997; MacLennan et al., 1998; Simmerman
et al., 1996). Remarkably, in our structure the orientation of
the side chains in domain II is in very good agreement with
both these mutagenesis studies and the proposed pentamer
model (Karim et al., 1998) (Fig. 9, E and F). The ribbon
diagram shows that all the ‘‘hot-spots’’ (violet) responsible
FIGURE 9 (A, C, and E) Ribbon representation of the minimized average
structure of AFA-PLB in DPC micelles (B, D, and F) compared to that in
organic solvent. The structure in DPC (A and C) exhibits all the hydrophobic
residues of the cytoplasmic domain (green) facing the micellar interior and
the hydrophilic residues (blue), including the phosphorylation sites Ser-16
and Thr-17 (magenta), pointing toward the bulk solvent. This is not the case
for the structure in organic solvent (B andD). Concomitantly, the residues of
domain II, deﬁned by mutagenesis studies to enhance (aqua) or reduce
(violet) monomer formation and inhibitory activity, are aligned on two
discrete faces for the AFA-PLB structure in DPC micelles (E) but
interspersed for the structure in organic solvent (F).
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for the interactions with the Ca-ATPase lie on the same face
of the TM domain, whereas the opposite face of domain II
comprises residues directly involved in the oligomeriza-
tion process (aqua). These functional data are not conﬁrmed
in the structure in chloroform/methanol.
Structural studies carried out on wild-type PLB in more
biologically relevant environments suggest that PLB forms
a single, continuous a-helix (Smith et al., 2001). It is
plausible that the authors measured the conformation of PLB
in the pentameric state, whereas in its monomeric form PLB
undergoes a conformational change that favors its inter-
actions with lipids. The dynamic equilibrium of PLB
monomer/pentamer formation and monomer/Ca-ATPase
interaction awaits further investigation.
This ‘‘L-shape’’ conformation of PLB in micelles and the
interhelical angle found between domain IA and domain II
agree with our previous results obtained from solid-state
NMR experiments on PLB in oriented lipid bilayers
(Mascioni et al., 2002b). Taken with the structure of
sarcolipin (Mascioni et al., 2002a), a PLB homolog in
skeletal muscle, these results support the hypothesis that
intramembrane regulatory interaction with Ca-ATPase is due
to a speciﬁc face of each of these small proteins, under-
scoring the importance of understanding PLB-lipid inter-
actions as a ﬁrst stage before its reversible interactions with
Ca-ATPase.
In summary, we report here the ﬁrst structure of
monomeric PLB obtained in a membrane-mimicking
environment in the absence of organic solvent. This
functional, monomeric form of PLB has been overexpressed
and puriﬁed from E. coli bacteria. Multidimensional NMR
experiments show that PLB comprises three distinct
domains: domain IA (residues 2–16), domain IB (residues
17–21), and domain II (residues 22–50). In DPC micelles,
PLB possesses an ‘‘L-shaped’’ conformation with an
interhelical angle of 80.3 6 21.68. The hydrogen bond
analysis carried out using exchange factors shows that
domain II has a strong network of hydrogen bonds, whereas
the cytoplasmic domain IA has a ‘‘weaker’’ helix as shown
by the higher values of the exchange factors. In addition, the
use of paramagnetic probes such as Mn21, 5-doxyl, and 16-
doxyl stearic acid allowed us to establish the orientation of
domain IA with respect to the DPC micelles. Our results
contradict the structures determined in organic mixtures but
are consistent with the amphipathic character of the
cytoplasmic domain. In our structure, most of the hydro-
philic residues point toward the bulk solvent, whereas the
hydrophobic residues are oriented toward the hydrocarbon
region of the micellar core. This particular orientation allows
the two phosphorylation sites to be more exposed for
interaction with their respective protein kinases. Ser-16 is
phosphorylated via PKA. Recently, Seidman and co-workers
proposed a model for human heart failure caused by a single
amino acid mutation, R9C, in PLB. Their ﬁndings indicate
that this mutant may sequester PKA, rendering it inactive
and thus decreasing the overall levels of PLB phosphoryla-
tion (Schmitt et al., 2003). The mechanism by which PKA
interacts with this region of phospholamban could be a prime
target for therapeutic intervention strategies. Finally, in our
structural model domain II shows a remarkable correlation
with previous mutagenesis studies, reporting the existence
of two discrete helical faces: one responsible for PLB’s
oligomerization and the other involved in the interaction
with Ca-ATPase.
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